10/1/2024LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...

10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003

10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201

10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...

10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC

10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...

10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...

10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...

9/27/2024Innovent Submits Marketing Application for Antibody Drug IBI112 for Ps...

9/27/2024Junshi Announces EC Approval of Toripalimab

9/12/2024Innovent's Mazdutide Outperforms Trulicity in Phase III Type 2 Diabete...

9/12/2024GenAssist Dosed the First DMD Clinical Base Editing Drug

9/10/2024China-US Research Team Develops Plant-based Nanoparticles for Brain C...

9/9/2024InnoCare Announces End-of-Phase 2 Meeting with FDA and Agreement to In...

9/9/2024Akeso, Summit's PD-1 Bispecific Beats Merck's Keytruda in China-Only S...

9/4/2024Innovent Granted U.S. Fast Track Designation for Advanced Melanoma Mo...

8/30/2024Virogin Biotech Won Chinese Breakthru Therapy Deisgnation for HCC Drug...

8/30/2024HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...

8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...

8/26/2024Chinese and U.S. Scientists Unveil New AI Model to Advance Drug Disco...

8/23/2024China Approves Innovent's Dupert for Advanced Lung Cancer Treatment

8/22/2024Jacobio Terminates Clinical Development of JAB-3068

8/22/2024Everest Medicines Announces Initiation of Clinical Trial for Personali...

8/21/2024GenFleet Wins Chinese Approval of Its KRAS G12C Inhibitor

Page:18/18 Total number of articles:534: [First][<<] [14] [15] [16] [17] [18] [>>] [End]